Arkolith/Insider Trading/CMMB/Form 4

Maryles Joel Michael

DirectorChemomab Therapeutics Ltd. (CMMB) · full profile →Form 4 · filed May 25, 2022
Net Buying
Open-Market Buys
$1K
Open-Market Sells
$0
Net Open-Market Flow
$1K
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 24, 2022Buy(P)400$2.89$1K1K
May 24, 2022Buy(P)33$2.76$911K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 7, 2022Grant(A)7K—$07K
Apr 19, 2021Grant(A)12K—$012K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001178913-22-002173) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML